News & Events

This is a listing of clinical trials recently activated by the University of Illinois Cancer Center Clinical Trials Office for patient enrollment. Click the study links below to learn details regarding the studies on clinicaltrials.gov. You can also search for other clinical trials on our website. For more information or questions about a study, email cancertrials@uic.edu or call 312-355-5112.

---

Protocol Title: RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 versus Docetaxel in Patients with Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC (RMC-6236-301)

• Sponsor: Revolution Medicines, Inc.
• Investigator: Frank Weinberg, MD, PhD

---

Protocol Title: KT-US-499-0150: A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma

• Sponsor: Kite Pharma, Inc.
• Investigator: Carlos Galvez, MD